| NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NCT04452565) | Biomed Industries, Inc. | 2022-06-15 |
| A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults (NCT05155982) | University of Saskatchewan | 2022-06-01 |
| COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia (NCT04381923) | University of Pennsylvania | 2021-11-15 |
| Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection (NCT04920838) | ANRS, Emerging Infectious Diseases | 2021-04-12 |
| Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (NCT04409873) | University of California, San Francisco | 2021-03-31 |
| Communication in ICU During COVID-19 (NCT04602351) | NMC Specialty Hospital | 2021-03-22 |
| Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis (NCT04707703) | Jeffrey Jenks, MD, MPH | 2021-03-16 |
| A Clinical Trial of COVAC-2 in Healthy Adults (NCT04702178) | University of Saskatchewan | 2021-02-10 |
| Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 (NCT04626089) | Laboratorios Silanes S.A. de C.V. | 2021-02-01 |
| Fluvoxamine for Adults With Mild to Moderate COVID-19 (NCT04711863) | Asan Medical Center | 2021-01-16 |
| Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 (NCT04732949) | Synairgen Research Ltd. | 2021-01-12 |
| CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals (NCT04402879) | University of Calgary | 2020-11-10 |
| Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 (NCT04371978) | Rabin Medical Center | 2020-10-01 |
| Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 (NCT04516811) | South African National Blood Service | 2020-09-21 |
| Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (NCT04365101) | Celularity Incorporated | 2020-09-02 |
| Treatment of SARS Caused by COVID-19 With Ruxolitinib (NCT04334044) | Grupo Cooperativo de Hemopatías Malignas | 2020-09-01 |
| Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia (NCT04519125) | Hospital Universitario San Ignacio | 2020-08-30 |
| An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection (NCT04522986) | Rohto Pharmaceutical Co., Ltd. | 2020-08-21 |
| Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 (NCT04477993) | Vanderson Geraldo Rocha | 2020-08-14 |
| Tocilizumab in Coronavirus-19 Positive Patients (NCT04423042) | University of Calgary | 2020-07-30 |
| Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (NCT04625985) | Laboratorios Silanes S.A. de C.V. | 2020-07-14 |
| Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients (NCT04379037) | Nemechek Technologies | 2020-06-27 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers (NCT04461353) | Pulmoquine Therapeutics, Inc | 2020-06-25 |
| COVID-19 Related Health and Infection Control Practices Among Dentists (NCT04423770) | American Dental Association | 2020-06-08 |
| A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 (NCT04402060) | Apellis Pharmaceuticals, Inc. | 2020-05-28 |
| Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. (NCT04354779) | AUVA | 2020-05-11 |
| Surgery and Lung Ultrasound in COVID-19 Infection (NCT04661631) | Fundacion Clinica Valle del Lili | 2020-05-08 |
| Host-pathogen Interactions During SARS-CoV-2 Infection (NCT04376476) | Hospices Civils de Lyon | 2020-05-05 |
| Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection (NCT04375098) | Pontificia Universidad Catolica de Chile | 2020-05-04 |
| African Covid-19 Critical Care Outcomes Study (NCT04367207) | University of Cape Town | 2020-05-01 |
| ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 (NCT04367740) | University of North Carolina, Chapel Hill | 2020-04-28 |
| Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients (NCT04359407) | Walid HABRE | 2020-04-27 |
| Monocytes and NK Cells Activity in Covid-19 Patients (NCT04375176) | Università degli Studi dell'Insubria | 2020-04-27 |
| Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection (NCT04361903) | Azienda USL Toscana Nord Ovest | 2020-04-25 |
| Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections (NCT04357938) | Jena University Hospital | 2020-04-15 |
| Beaumont Health Large-scale Automated Serologic Testing for COVID-19 (NCT04349202) | Corewell Health East | 2020-04-10 |
| Pro-thrombotic Status in Patients with SARS-Cov-2 Infection (NCT04343053) | University Hospital of Ferrara | 2020-04-08 |
| Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (NCT04333368) | Assistance Publique - Hôpitaux de Paris | 2020-04-06 |
| Pulmonary Fibrosis During Severe COVID-19 Pneumonia (NCT04987528) | Hôpital Européen Marseille | 2020-03-11 |
| Evaluation of Sedation in COVID-19 ARDS (NCT04667936) | Goethe University | 2020-03-01 |
| Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP) (NCT04360486) | U.S. Army Medical Research and Development Command | |